Table 5 Predictive factors for progression-free survival after comparing the expected group and the group with the worst response to therapy

From: A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

	Univariate			Multivariate
				MSKCC risk patients			Heng risk patients
Variables	OR	P-value	95 % CI	HR	P-value	95 % CI	HR	P-value	95 % CI
Hemoglobin low	3.29	0.003	1.49–7.27	3.25	0.006	1.41–7.52	2.87	0.014	1.23–6.66
Platelet high	1.75	0.288	0.62–4.91
low	1.11	0.916	0.15–8.24
Lymphocyte high	0.56	0.503	0.1–3.08				0.26	0.242	0.03–2.47
Low	2.69	0.016	1.2–6.02				2.05	0.098	0.88–4.78

Back to article page